Nuveen Asset Management, LLC Iveric Bio, Inc. Transaction History

Nuveen Asset Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$26.24 - $39.63 $4.52 Million - $6.83 Million	-172,312 Reduced 14.51%	1,015,026 $39.9 Million
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $6.91 Million - $9.09 Million	-369,955 Reduced 23.76%	1,187,338 $28.9 Million
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $2.3 Million - $3.2 Million	133,638 Added 9.39%	1,557,293 $33.3 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $3.74 Million - $7.39 Million	397,709 Added 38.77%	1,423,655 $25.5 Million
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $2.17 Million - $4.49 Million	237,825 Added 30.18%	1,025,946 $9.87 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $91,161 - $126,275	7,503 Added 0.96%	788,121 $12.4 Million
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $322,971 - $438,569	-23,353 Reduced 2.9%	780,618 $6.78 Million
Q3 2021 Nov 12, 2021	BUY	$7.07 - $17.5 $3.28 Million - $8.12 Million	463,725 Added 136.29%	803,971 $6.99 Million
Q2 2021 Aug 16, 2021	SELL	$5.69 - $7.17 $2.46 Million - $3.1 Million	-432,156 Reduced 55.95%	340,246 $2.15 Million
Q1 2021 May 17, 2021	SELL	$5.08 - $6.89 $1.21 Million - $1.64 Million	-238,354 Reduced 23.58%	772,402 $4.77 Million
Q4 2020 Feb 16, 2021	BUY	$5.65 - $7.66 $3.56 Million - $4.82 Million	629,507 Added 165.12%	1,010,756 $6.98 Million
Q3 2020 Nov 16, 2020	BUY	$4.01 - $6.29 $669,714 - $1.05 Million	167,011 Added 77.96%	381,249 $2.15 Million
Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $655,568 - $1.41 Million	214,238 New	214,238 $1.09 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.